Today: 20 March 2026
Subscribe
Browse Category

ASX:AMP 11 December 2025 - 27 February 2026

Australia stock market today: ASX 200 slips as miners sink, RBA rate call looms

Australia stock market today: ASX 200 slips as miners sink, RBA rate call looms

ASX 200 fell 0.65% to 8,869.1 as miners and gold stocks slumped, with Rio Tinto down 3.5% and BHP off 1.8%. Hotter-than-expected core inflation pushed markets to price in a 75% chance of an RBA rate hike next week. The Australian dollar slipped to 70.02 U.S. cents. Whitehaven reported a 21% jump in quarterly coal output to 11 million tonnes.
30 January 2026
·········
ASX 200 Edges Higher as Miners Rally and Rate Jitters Grow – Australia Stock Market Today, 11 December 2025

ASX 200 Edges Higher as Miners Rally and Rate Jitters Grow – Australia Stock Market Today, 11 December 2025

The S&P/ASX 200 closed up 12.6 points at 8,592 on Thursday, rising 0.15% after a volatile session. Miners led gains as iron ore stayed above $100 a tonne, while tech stocks fell. The US Fed cut rates by 25 basis points but signaled slower easing ahead. Australia’s unemployment rate held at 4.3%, fueling debate over a possible RBA hike in early 2026.
11 December 2025
··········

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop